|
[1]Wong F, Blendis L.New challenge of hepatorenal syndrome:pre-vention and treatment[J].Hepatology, 2001, 34 (6) ∶1242-1251.
|
|
[2] 严颖, 江元森, 姚集鲁.肝肾综合征[J].国外医学内科学分册, 2002, 29 (5) ∶185-187.
|
|
[3]刘建军, 智红, 刘芙容.肝肾综合征发病机制与高渗氯化钠溶液的应用[J].临床肝胆病杂志, 2001, 17 (1) ∶60-61.
|
|
[4]Arroyo V, Gines P, Gerbes AL, et al.Definition and diagnostic cri-teria of refractory ascites and hepatorenal syndrome in cirrhosis[J].Hepatology, 1996, 23 (1) ∶164-176.
|
|
[5]Loon NR, WilcoxCS, Unwin RJ.Mechanismof impaired response to furosemide during prolonged therapy[J].J Clin Invest, 1989, 83 (1) ∶113-126.
|
|
[6]Gregory PB, Broelcelschen PH, Hill MD, et al.Complications of diu-resis in the alcoholic patient with ascites:a controlled trial[J].Gas-troenterology, 1977, 7 (3) ∶534-538.
|
|
[7]Ruiz-del-Arbol L, Monescillo A, Jimenez W, et al.Paracentesis-induced circulatory dysfunction:mechanism and the effect on he-patic hemodynamics in cirrhosis[J].Gastroenterology, 1997, 113 (2) ∶579-586.
|
|
[8]Salo J, Gines A, Gines P, et al.Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in pa-tients with cirrhosis[J].J Hepatol, 1997, 27 (4) ∶645-653.
|
|
[9]Gines A, Escorsell, Gines P, et al.Incidence, predictive factors and prognosis of the hepatorenal syndrome in cirrhosis and ascites[J].Gastroenterology, 1993, 105 (1) ∶229-236.
|
|
[10]Afessa B, Kublis PS.Upper gastrointestinal bleeding in patients with hepatic cirrhosis:clinical course and mortality prediction[J].Am J Gastroenterology, 2000, 95 (2) ∶484-489.
|
|
[11]Follo A, Llovet JM, Navasa M, et al.Renal impairment after spon-taneous bacterial peritonitis in cirrhosis:incidence, clinical course, predictive factors and prognosis[J].Hepatology, 1994, 20 (6) ∶1495-1501.
|
|
[12]Navasa M, Rodes J.Managememt of ascites in the patient with por-tal hypertension with emphasis on spontaneous bacterial peritonitis[J].Semin Gastrointest Dis, 1997, 8 (4) ∶200-209.
|
|
[13]Sort P, Navasa M, Arroyo V, et al.Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spon-taneous bacterial peritonitis[J].N Engl J Med, 1999, 341 (6) ∶403-409.
|
|
[14]Holt S, Marley R, Fernando B, et al.Acute cholestasis-induced renal failure:effects of antioxidants and ligands for the thromboxane A2receptor[J].Kidney Int, 1999, 55 (1) ∶271-277.
|
|
[15]顾锡炳, 刘霞英, 徐月琴, 等.不限钠饮食与限钠饮食对肝硬化血肾素、血管紧张素Ⅱ、醛固酮及肾血流量的影响[J].江苏医药, 2008, 34 (12) ∶1303-1304.
|
|
[16]Rimola A, Garcia-Tsao G, Navasa M, et al.Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis:a consensus document.International Ascites Club[J].J Hepatol, 2000, 32 (1) ∶142-153.
|
|
[17]Angeli P, Volpin R, Gerunda G, et al.Reversal of typeⅠhepato-renal syndrome with the administration of midodrine and octreotide[J].Hepatology, 1999, 29 (6) ∶1690-1697.
|
|
[18]雷静静, 周力.去甲肾上腺素治疗Ⅰ型肝肾综合征近期疗效观察[J].临床肝胆病杂志, 2005, 21 (6) ∶358-359.
|
|
[19]Lenz k, Hortnagl H, Draml W, et al Beneficial effects of8-orni-thin vasopressin on renal dysfunction in decompensated cirrhosis[J].Gut, 1989, 30 (1) ∶90-96.
|
|
[20]Aenz K, Hortnagl H, Druml W, et al.ornipressin in the treat-ment of functional renal failure in decompensated liver cirrhosis, effects on renal hemodynamics and atrial natriuretic factor[J].Gas-troenterology, 1991, 101 (4) ∶1060-1067.
|
|
[21]Hadengue A, Gadano A, Moreau R, et al.Beneficial effects of the2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome[J].J Hepatol, 1998, 29 (4) ∶565-570.
|
|
[22]Soper CP, Latif AB, Bending MR.Amelioration of hepatorenal syndrome with selective endothelin-A antagonist[Letter][J].Lancet, 1996, 347∶1842-1843.
|
|
[23]Holt S, Goodier D, Marley R, et al.Improvement in renal function in hepatorenal syndrome with N-acetylcysteine[J].Lancet, 1999, 353∶294-295.
|
|
[24]张艳梅, 刘东屏.肝肾综合征治疗进展[J].中国医师杂志, 2007, 9 (7) ∶1003-1004.
|
|
[25]Capling RK, Bastani B.The clinical course of patients with typeⅠhepatorenal syndrome maintained on hemodialysis[J].Ren Fail, 2004, 26 (5) ∶563-568.
|
|
[26]Guevara M, Gines P, Bandi JC, et al.Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome∶effects on renal function and vasoactive systems[J].Hepatology, 1998, 28 (2) ∶416-422.
|
PDF下载 ( 173 KB)
本文二维码
下载:
